Status:
TERMINATED
RapidTEG MA Validation
Lead Sponsor:
Haemonetics Corporation
Conditions:
Coagulation
Platelet Function
Eligibility:
All Genders
18+ years
Brief Summary
During normal physiological conditions hemostasis (the ability of blood to clot) is kept in homeostatic balance by feedback mechanisms. These mechanisms involve an extremely complex series of steps on...
Eligibility Criteria
Inclusion
- Patient age \> 18 years old
- Patient is either a Trauma patient OR is diagnosed with known cardiovascular disease.
- Samples must be tested within the recommended timeline (4-6 minutes for non-citrated and between 15 minutes and 2 hours for citrated)
Exclusion
- Patients who have been placed on anticoagulation prophylaxis for other conditions (not CPB/PCI related).
- Patients who have established hemostasis system abnormalities (congenital or other).
- Samples identified as affected by testing errors by lab staff.
Key Trial Info
Start Date :
July 1 2011
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
October 1 2012
Estimated Enrollment :
17 Patients enrolled
Trial Details
Trial ID
NCT01428102
Start Date
July 1 2011
End Date
October 1 2012
Last Update
September 16 2013
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
Sinai Center for Thrombosis Research
Baltimore, Maryland, United States, 21215
2
Univserity of Tennessee Health Sciences Center
Knoxville, Tennessee, United States, 37996-1529